New study offers hope for treatment of hypoactive sexual desire disorder
A new study suggests that bupropion hydrochloride sustained-release tablets may be an effective treatment for HSDD in females, with significant increases in episodes of sexual arousal and interest. Researchers reported encouraging results, with nearly 40% of participants showing improvement in their sexual desire.